Clearpoint Neuro Inc (CLPT)

$6.20 0.20 (3.13%)

16:00 EDT CLPT Stock Quote Delayed 30 Minutes

CLPT Stock Earnings: ClearPoint Neuro Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 7, 2024

CLPT stock results show that ClearPoint Neuro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

7 Penny Stocks That Could Make You a Fortune (If You Dare)

The 3 Most Promising MedTech Stocks to Invest In Now

The Top 7 Under-$15 Stocks to Buy in March 2024

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 78,994

Day's Range $6.09 - $6.42

52-Week Range $4.05 - $8.99

Dividend & Yield N/A (N/A)

CLPT Stock Predictions, Articles, and Clearpoint Neuro Inc News

From InvestorPlace
From the Web

Tech Trailblazers: 7 Small-Cap Stocks on the Verge of a Breakthrough

By Jeremy Flint, InvestorPlace Contributor Feb 28, 2024

These small-cap tech stocks are well on their way to a meteoric and historic rise, but it isn't too late to jump on the bandwagon.

The 3 Up-and-Coming Stocks That Could Make Your February Unforgettable

By Jeremy Flint, InvestorPlace Contributor Feb 15, 2024

Finding an up-and-coming stock worth investing in is harder than it used to be, but you don't have to look far if you check out this list.

The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.

By Ian Bezek, InvestorPlace Contributor Feb 15, 2024

Looking for the next generational winner in healthcare stocks? These are three of the top prospects today.

3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List

By Jeremy Flint, InvestorPlace Contributor Feb 9, 2024

These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why.

3 Small-Cap Healthcare Stocks to Buy and Hold Forever: January 2024

By Jeremy Flint, InvestorPlace Contributor Jan 25, 2024

Small-cap healthcare stocks combine relative cheapness with advanced innovations including AI, automation, and more.

7 Small-Cap Stocks With Huge Potential Flying Under the Radar

By Jeremy Flint, InvestorPlace Contributor Jan 10, 2024

Small-cap stocks are massively undervalued and represent a unique investment opportunity for traders in 2024.

7 Solid Small-Caps for 2024 and Beyond

By Jeremy Flint, InvestorPlace Contributor Dec 5, 2023

Small-cap stocks are positioned to beat the biggest companies in 2024 as risk tolerance climbs and shares remain undervalued

3 High-Potential Small-Cap Stocks for Investors With Strong Stomachs

By Ian Bezek, InvestorPlace Contributor May 31, 2023

Small-cap stocks can be risky, and all three of these companies are facing adversity. But they could be home run investments.

3 Healthcare Stocks With Huge Growth Potential

By Ian Bezek, InvestorPlace Contributor Apr 24, 2023

It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Oct 18, 2022

It's time for another look at the biggest pre-market stock movers as we check out what's happening with shares on Tuesday morning!

ClearPoint Neuro prices offering of about 2.3M shares (NASDAQ:CLPT)

From Seeking Alpha Feb 29, 2024

ClearPoint Neuro announces pricing of its underwritten public offering of 2,307,694 shares of common stock at $6.50 per share, with an option for additional...

ClearPoint Neuro stock falls 10% after it announces an equity raise (NASDAQ:CLPT)

From Seeking Alpha Feb 28, 2024

ClearPoint Neuro (CLPT) announces a public offering of common stock and grants underwriters an option to purchase additional shares.

ClearPoint Neuro receives EU okay for devices, Calif. plant (NASDAQ:CLPT)

From Seeking Alpha Jan 22, 2024

ClearPoint Neuro (CLPT) has received EU clearance for its SmartTwist MR Hand Drill and SmartTip MR Drill Kit along with an updated certification for its new California plant.

ClearPoint Neuro gets FDA clearance for SmartFrame OR (NASDAQ:CLPT)

From Seeking Alpha Jan 16, 2024

ClearPoint Neuro(CLPT) has received FDA clearance for its SmartFrame OR Stereotactic System for neurological procedures. Read more here.

ClearPoint Neuro stock in pact with UCB for gene therapy (NASDAQ:CLPT)

From Seeking Alpha May 24, 2023

ClearPoint Neuro (CLPT) announced Wednesday a licensing deal with UCB (UCBJF) to develop drug delivery platforms for Belgian firm's gene therapies. Read more here.

Analysts Are Bullish on Top Healthcare Stocks: ClearPoint Neuro (CLPT), Avidity Biosciences (RNA)

From TipRanks Nov 9, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ClearPoint Neuro (

ADVERTISEMENT